BASi Announces First-of-Its-Kind Pivotal Study With Data Sciences International

Published: Dec 07, 2012

WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--BASi (Bioanalytical Systems, Inc.) (NASDAQ: BASI) today announced that it is collaborating with Data Sciences International (DSI), a biomedical research company focused on preclinical systems physiology and pharmacology, to conduct a first-of-its-kind study combining BASi’s Culex®-L automated sampling system with DSI’s newest large animal telemetry technology, PhysioTel™ Digital.

Back to news